Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Tim Evans is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/26/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
11/16/2023 | CTLT | Buy Now | Catalent | — | — | Tim Evans56% | $50 → $42 | Maintains | Equal-Weight | Get Alert |
07/20/2023 | CTLT | Buy Now | Catalent | — | — | Tim Evans56% | → $43 | Initiates | → Equal-Weight | Get Alert |
03/08/2018 | FMI | Buy Now | Foundation Medicine | — | — | Tim Evans56% | $67 → $80 | Maintains | Market Perform | Get Alert |
02/28/2018 | MEDP | Buy Now | Medpace Hldgs | $310.69 | -88.73% | Tim Evans56% | $38 → $35 | Maintains | Market Perform | Get Alert |
02/28/2018 | BIO | Buy Now | Bio-Rad Laboratories | $243.98 | 14.76% | Tim Evans56% | $290 → $280 | Maintains | Outperform | Get Alert |
01/02/2018 | ILMN | Buy Now | Illumina | $93.17 | — | Tim Evans56% | — | Upgrade | Market Perform → Outperform | Get Alert |
10/27/2017 | WST | Buy Now | West Pharmaceutical Servs | $218.87 | -48.83% | Tim Evans56% | $105 → $112 | Maintains | Outperform | Get Alert |
10/25/2017 | ILMN | Buy Now | Illumina | $93.17 | 120.04% | Tim Evans56% | $200 → $205 | Maintains | Market Perform | Get Alert |
10/20/2017 | DGX | Buy Now | Quest Diagnostics | $177.83 | -51.64% | Tim Evans56% | $88 → $86 | Maintains | Market Perform | Get Alert |
10/12/2017 | DGX | Buy Now | Quest Diagnostics | $177.83 | -50.51% | Tim Evans56% | → $88 | Reinstates | Underperform → Market Perform | Get Alert |
10/12/2017 | LH | Buy Now | Laboratory Corp | $260.59 | -32.84% | Tim Evans56% | → $175 | Reinstates | Market Perform → Outperform | Get Alert |
09/20/2017 | CTLT | Buy Now | Catalent | — | — | Tim Evans56% | $39 → $43 | Maintains | Outperform | Get Alert |
07/13/2017 | TECH | Buy Now | Bio-Techne | $51.84 | — | Tim Evans56% | — | Initiates | → Market Perform | Get Alert |
07/13/2017 | PKI | Buy Now | PerkinElmer | — | — | Tim Evans56% | → $72 | Initiates | → Market Perform | Get Alert |
07/13/2017 | DHR | Buy Now | Danaher | $199.19 | -54.82% | Tim Evans56% | → $90 | Initiates | → Market Perform | Get Alert |
07/13/2017 | MTD | Buy Now | Mettler-Toledo Intl | $1.18K | — | Tim Evans56% | — | Upgrade | Market Perform → Outperform | Get Alert |
07/13/2017 | BIO | Buy Now | Bio-Rad Laboratories | $243.98 | 2.47% | Tim Evans56% | → $250 | Initiates | → Outperform | Get Alert |
07/13/2017 | BRKR | Buy Now | Bruker | $41.80 | — | Tim Evans56% | — | Downgrade | Market Perform → Underperform | Get Alert |
07/13/2017 | A | Buy Now | Agilent Technologies | $119.99 | — | Tim Evans56% | — | Upgrade | Market Perform → Outperform | Get Alert |
05/03/2017 | MEDP | Buy Now | Medpace Hldgs | $310.69 | — | Tim Evans56% | — | Downgrade | Outperform → Market Perform | Get Alert |
05/03/2017 | INCR | Buy Now | Intercure | $1.55 | — | Tim Evans56% | — | Downgrade | Outperform → Market Perform | Get Alert |
10/28/2016 | WST | Buy Now | West Pharmaceutical Servs | $218.87 | — | Tim Evans56% | — | Upgrade | Market Perform → Outperform | Get Alert |
09/21/2016 | WST | Buy Now | West Pharmaceutical Servs | $218.87 | — | Tim Evans56% | — | Downgrade | Outperform → Market Perform | Get Alert |
09/06/2016 | MEDP | Buy Now | Medpace Hldgs | $310.69 | — | Tim Evans56% | — | Initiates | → Outperform | Get Alert |
08/03/2016 | BRKR | Buy Now | Bruker | $41.80 | — | Tim Evans56% | — | Downgrade | Outperform → Market Perform | Get Alert |
06/21/2016 | CTLT | Buy Now | Catalent | — | — | Tim Evans56% | — | Upgrade | Market Perform → Outperform | Get Alert |
03/22/2016 | WST | Buy Now | West Pharmaceutical Servs | $218.87 | — | Tim Evans56% | — | Initiates | → Outperform | Get Alert |
12/22/2015 | CTLT | Buy Now | Catalent | — | — | Tim Evans56% | — | Downgrade | Outperform → Market Perform | Get Alert |
09/16/2015 | FMI | Buy Now | Foundation Medicine | — | — | Tim Evans56% | — | Downgrade | Outperform → Market Perform | Get Alert |
09/09/2014 | CTLT | Buy Now | Catalent | — | — | Tim Evans56% | — | Initiates | → Outperform | Get Alert |